|
Real-time Estimate
Cboe Europe
08:58:51 2026-08-27 am EDT
|
5-day change | 1st Jan Change | ||
| 12,170.00 GBX | -0.52% |
|
+0.91% | -11.82% |
| 04:30am | AstraZeneca, Amgen Phase 3 Trial Shows Tezspire Eases Swallowing Difficulties for EoE Patients | MT |
| 03:36am | AstraZeneca and Amgen announce positive Tezspire trial results in EoE | AN |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bearish | Neutral |
| Resistance | 13,134 | 13,134 | 15,542 |
| Spread/Res. | -7.22% | -7.22% | -21.59% |
| Spread/Supp. | +6.34% | +6.34% | +10.78% |
| Support | 11,460 | 11,460 | 11,000 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- AZN Stock
- Charts AstraZeneca PLC
Select your edition
All financial news and data tailored to specific country editions
